TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Bionomen AB
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
5,994
|
11,452
|
5,943 |
| Financial expenses |
4
|
4
|
4 |
| Earnings before taxes |
440
|
2,052
|
754 |
| EBITDA |
433
|
2,056
|
762 |
| Total assets |
2,769
|
3,387
|
2,162 |
| Current assets |
2,756
|
3,367
|
2,134 |
| Current liabilities |
468
|
691
|
1,193 |
| Equity capital |
2,130
|
2,519
|
895 |
| - share capital |
32
|
34
|
33 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
76.9%
|
74.4%
|
41.4% |
| Turnover per employee |
2,997
|
5,726
|
2,972 |
| Profit as a percentage of turnover |
7.3%
|
17.9%
|
12.7% |
| Return on assets (ROA) |
16.0%
|
60.7%
|
35.1% |
| Current ratio |
588.9%
|
487.3%
|
178.9% |
| Return on equity (ROE) |
20.7%
|
81.5%
|
84.2% |
| Change turnover |
-5,079
|
5,479
|
643 |
| Change turnover % |
-46%
|
92%
|
12% |
| Chg. No. of employees |
0
|
0
|
-1 |
| Chg. No. of employees % |
0%
|
0%
|
-33% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.